Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Akero Therapeutics, Inc. | Director | Common Stock | 1.2M | $53.9M | $44.92 | Jun 3, 2025 | Indirect |
Olema Pharmaceuticals, Inc. | Director | Common Stock | 1.8M | $5.72M | $3.18 | Dec 13, 2024 | Indirect |
Akero Therapeutics, Inc. | Director | Common Stock | 11.6K | $520K | $44.92 | Jun 3, 2025 | Direct |
Akero Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 26K | Jun 8, 2024 | Direct | ||
Olema Pharmaceuticals, Inc. | Director | Stock Option (right to buy) | 24.2K | Jun 11, 2025 | Direct | ||
ALX ONCOLOGY HOLDINGS INC | Director | Stock option (right to buy) | 12K | Jun 11, 2021 | Direct |